[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2024007679A - Compuestos intermedios cristalinos. - Google Patents

Compuestos intermedios cristalinos.

Info

Publication number
MX2024007679A
MX2024007679A MX2024007679A MX2024007679A MX2024007679A MX 2024007679 A MX2024007679 A MX 2024007679A MX 2024007679 A MX2024007679 A MX 2024007679A MX 2024007679 A MX2024007679 A MX 2024007679A MX 2024007679 A MX2024007679 A MX 2024007679A
Authority
MX
Mexico
Prior art keywords
crystalline intermediates
epoxytigliane
compounds
crystalline
intermediates
Prior art date
Application number
MX2024007679A
Other languages
English (en)
Inventor
Luca Domenighini
Lorena Fumagalli
Andrea Gambini
Nicola Sardone
Original Assignee
QBiotics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2021904153A external-priority patent/AU2021904153A0/en
Application filed by QBiotics Pty Ltd filed Critical QBiotics Pty Ltd
Publication of MX2024007679A publication Critical patent/MX2024007679A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

En la presente se proporciona un compuesto intermedio cristalino útil en la fabricación de compuestos de 6,7-epoxitigliano. También se proporcionan métodos para elaborar los compuestos de 6,7-epoxitigliano usando los compuestos intermedios cristalinos, así como compuestos de 6,7-epoxitigliano de alta pureza que son capaces de producirse usando el compuesto intermedio cristalino.
MX2024007679A 2021-12-21 2022-12-21 Compuestos intermedios cristalinos. MX2024007679A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2021904153A AU2021904153A0 (en) 2021-12-21 Crystalline Intermediates
PCT/AU2022/051546 WO2023115123A1 (en) 2021-12-21 2022-12-21 Crystalline intermediates

Publications (1)

Publication Number Publication Date
MX2024007679A true MX2024007679A (es) 2024-07-09

Family

ID=86900792

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024007679A MX2024007679A (es) 2021-12-21 2022-12-21 Compuestos intermedios cristalinos.

Country Status (8)

Country Link
EP (1) EP4452958A1 (es)
KR (1) KR20240125023A (es)
CN (1) CN118451065A (es)
AU (1) AU2022417285A1 (es)
CA (1) CA3240884A1 (es)
IL (1) IL313719A (es)
MX (1) MX2024007679A (es)
WO (1) WO2023115123A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2634469C (en) * 2005-12-23 2012-08-21 Qbiotics Limited Tiglien-3-one derivatives
BR112015026388A8 (pt) * 2013-04-18 2019-12-31 Qbiotics Ltd uso de um composto de epoxi-tigliane, composto e composição farmacêutica
JP2019523303A (ja) * 2016-07-28 2019-08-22 キューバイオティクス リミティド 治療方法
MY197427A (en) * 2017-03-23 2023-06-16 QBiotics Pty Ltd Combination therapy for the treatment or prevention of tumours
KR20210152531A (ko) * 2019-04-12 2021-12-15 큐바이오틱스 피티와이 리미티드 종양을 치료하는 방법
US20220313648A1 (en) * 2019-06-19 2022-10-06 QBiotics Pty Ltd Biofilm disruption
JP6872659B1 (ja) * 2020-07-20 2021-05-19 陽吉 小川 磁界発生装置、磁界発生システム，照射対象物の生産方法、照射対象物、液体、水、加湿器、加湿方法、プログラム、コンピュータが読み取り可能な記憶媒体

Also Published As

Publication number Publication date
EP4452958A1 (en) 2024-10-30
KR20240125023A (ko) 2024-08-19
IL313719A (en) 2024-08-01
CA3240884A1 (en) 2023-06-29
WO2023115123A1 (en) 2023-06-29
CN118451065A (zh) 2024-08-06
AU2022417285A1 (en) 2024-07-11

Similar Documents

Publication Publication Date Title
MX2015016947A (es) Metodos para producir derivados de acido graso omega-hidroxilados.
WO2012065114A3 (en) Polyketal adducts, methods of manufacture and uses thereof
MX2016013647A (es) Metodo para preparar ciclicamente taurina a partir de hidroxietil acido sulfonico de metal alcalino sal y vinilo acido sulfonico de metal alcalino sal.
MY198086A (en) Method for producing substituted 5-fluoro-1h-pyrazolopyridines
CY1111690T1 (el) Μεθοδος για την παρασκευη δροσπιρενονης
MX2021008439A (es) Metodos novedosos y herramientas relacionadas para la conversion de cbd en thc.
EP2993225A3 (en) Novel mutant microorganism producing succinic acid simultaneously using sucrose and glycerol, and method for preparing succinic acid using same
NZ603653A (en) Processes for the preparation of dipyridamole
EA201201666A1 (ru) Промежуточные соединения агомелатина и способ их получения
PL3739115T3 (pl) Zoptymalizowane wytwarzanie tektury opakowaniowej do stosowania jako fluting
MX2023011976A (es) Sintesis de compuestos analogos de rapamicina.
MX2024007679A (es) Compuestos intermedios cristalinos.
EP4222107A4 (en) ARRANGEMENT TO OPTIMIZE HYDROGEN PRODUCTION
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
MX2023012460A (es) Una forma de tafamidis en estado solido y un proceso para su preparacion.
MX2023000059A (es) Metodo de preparacion de compuesto de fenilisoxazolina.
AR047672A1 (es) Metodo para producir compuesto 4-nitroimidazol
MX2023005954A (es) Procesos para preparar citrato de arimoclomol e intermediarios del mismo.
NZ589496A (en) Processes and compounds for the preparation of normorphinans
MY147894A (en) Process for preparing intermediate compound for synthesizing an antiulcerant
ZA202006181B (en) Process for the preparation of iloprost
WO2020159963A8 (en) Cell populations with improved production and therapeutic characteristics
MX2021002311A (es) Metodo para producir un compuesto tetraciclico.
TW200724527A (en) Process for the production of hydroxyalkylmaleimides
ZA200704732B (en) Process for preparing high levels of interferon beta